GEV GE Vernova Inc

GE Vernova is a global energy company providing grid solutions, wind turbines, gas turbines, and electrification software for power generation and transmission. Sector: Industrials.

GE Vernova Inc (GEV) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

On the question of capital productivity, ROIC is 19.32%, WACC is 12.20%, and the economic spread is 7.13%. On balance, returns on capital just exceed funding costs, implying limited but real value creation at the margin. Supporting metrics show ROE at 83.61% and ROA at 9.06%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company that is value-creative but with less room for execution slippage.

From a market pricing perspective, trailing P/E of 30.19, forward P/E of 62.02, PEG of 1.75. With trailing and forward P/E closely aligned, the market appears to be pricing the company on the assumption that earnings remain broadly stable near term. On a growth-adjusted basis, valuation appears reasonable relative to expected growth. The company carries an aggregate current ratio of 0.89, pointing to constrained near-term balance sheet coverage. The overall valuation picture is one where the market is paying for a specific earnings and growth outcome — and where any deviation from that path would likely pressure multiples.

The margin stack reads as follows: gross margin sits at 20.11%, operating margin at 5.02%, and free cash flow margin at 19.11%. Gross margins are in the moderate range, typical of sectors where direct costs consume a larger share of revenue. The company's operating margins leave limited room between gross profit and operating earnings — a sign of cost pressure. FCF margins are constructive here, reflecting the company that generate cash reliably after reinvestment requirements. The profile is not weak, but it is uneven enough that execution and cost control remain central to the forward case.

The forward view combines two signals: the estimated 12-month price change of 8.43%, where analyst estimates suggest only incremental upside absent a positive surprise, while TTM revenue growth of 16.27% suggesting the company is growing revenues at a measured, sustainable pace. The forward EPS growth estimate of -51.3% is negative, which complicates the valuation case and suggests current multiples may not be as defensible on a forward basis. One metric reflects operational reality, the other market expectation — both are useful inputs, but neither should be read in isolation. The interaction between revenue execution and analyst repricing will ultimately determine how closely realized returns track current expectations. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

There is enough quality in the profile to avoid outright concern, but not enough uniform strength to take high conviction in a direction. Patience has merit here.

This assessment is based solely on the quantitative metrics presented above and does not constitute financial advice. Investors should consider their own risk tolerance and conduct independent research before making investment decisions.